My watch list
my.bionity.com  
Login  
NEWS
Current news

Clinical Trial Moves Stem Cell Therapy for ALS Patients One Step Closer to Reality

Stem cells are a safe therapy for patients with amyotrophic lateral sclerosis (ALS), according to the results of a recently completed phase 1 clinical trial. Details of the trial, conducted by scientists in South Korea, are published in STEM CELLS Translational Medicine. The trial was the n ... more

Neural stem cell implants hold promise for treating epilepsy, other neurological disorders

A team of University of Florida Health researchers has successfully transplanted human stem cells that developed into fully functional neurons in a mouse model, a promising step toward finding new treatments for epilepsy and other neurological disorders. The findings are particularly encour ... more

QIAGEN partners with sequencing provider

QIAGEN N.V. announced that it has expanded its relationship with BG to provide QIAGEN’s Ingenuity® Variant Analysis™ in integrated bioinformatics for all customers of BGI’s sequencing services. Under the reseller agreement, BGI customers will receive sequencing data generated from their sam ... more

Scientists find new link between diabetes and Alzheimer's

Researchers have uncovered a unique connection between diabetes and Alzheimer's disease, providing further evidence that a disease that robs people of their memories may be affected by elevated blood sugar, according to scientists at Washington University School of Medicine in St. Louis.Whi ... more

Decoding DNA's phonebook

New clues about diseases like inflammatory bowel disorder may be found thanks to a new genomic interactions catalogue by a group of researchers in Japan and the United Kingdom. This research is published in Nature Genetics.Biologists have compiled the most comprehensive catalogue of promote ... more

First miniature synchrotron now in commercial operation

Lyncean Technologies, Inc. announced the commercial operation of a Compact Light Source (CLS), the world's first miniature synchrotron X-ray source employing state-of-the-art laser and electron beam technology.The Lyncean CLS was purchased in December 2012 by researchers from the newly form ... more

SYGNIS signs non-exclusive distribution agreement with Cambridge Bioscience Ltd. for UK and Ireland

SYGNIS AG announced a distribution agreement with Cambridge Bioscience for the commercialization of SYGNIS’ proprietary product portfolio in the UK and Ireland.Under the terms of the agreement, Cambridge Bioscience will promote, market, sell and support TruePrime™ products for primer-free W ... more

AmpliPhi Biosciences Announces New CEO

AmpliPhi BioSciences Corporation announced that Scott Salka has been appointed as the new CEO. Mr. Salka will replace Interim CEO and Chairman of AmpliPhi, Jeremy Curnock Cook, effective May 18. Mr. Curnock Cook will remain in his role as Chairman.Since 2010, Mr. Salka has served as CEO of ... more

NIH launches research to gaze deeply into your eyes

Five bold projects will develop new technology to noninvasively image cells of the eye in unprecedented detail. The National Eye Institute (NEI) announced the awards as part of its Audacious Goals Initiative. NEI has committed $3.8 million to the projects in 2015 and up to $17.9 million ove ... more

A ranking of environmental chemicals

How dangerous are environmental chemicals and what is their effect on human health? In a project funded by the Austrian Science Fund FWF, the pharmacist Daniela Schuster is currently developing a computer-based "early warning system" for potentially dangerous substances.In our daily lives w ... more

All news

QIAGEN partners with sequencing provider

QIAGEN N.V. announced that it has expanded its relationship with BG to provide QIAGEN’s Ingenuity® Variant Analysis™ in integrated bioinformatics for all customers of BGI’s sequencing services. Under the reseller agreement, BGI customers will receive sequencing data generated from their sam ... more

Decoding DNA's phonebook

New clues about diseases like inflammatory bowel disorder may be found thanks to a new genomic interactions catalogue by a group of researchers in Japan and the United Kingdom. This research is published in Nature Genetics.Biologists have compiled the most comprehensive catalogue of promote ... more

BIOCITECH: Over 20% increase in revenue for the residents in 2014

Biocitech announced the 2014 results achieved by its residents. Biocitech residents submitted encouraging results for 2014, with growth in many areas. The overall revenue for the complex’s residents grew by 21%, from €51.3 million ($55.5 million) in 2013 to €62 million ($67 million) in 2014 ... more

TxCell appoints Chief Executive Officer

TxCell SA announces the appointment of Stéphane Boissel as Chief Executive Officer (CEO). In addition, Dr. Miguel Forte, previously SVP Clinical and Regulatory, is promoted to Chief Operating Officer. Stéphane Boissel succeeds Damian Marron, who has resigned from the company to pursue other ... more

IDT’s San Diego Manufacturing Facility Receives ISO 14001 Certification

Integrated DNA Technologies (IDT) announces that its San Diego, California, manufacturing facility has attained ISO 14001:2004 certification for its environmental management systems. Now, both of IDT’s US manufacturing sites (Coralville, IA and San Diego, CA) have ISO 14001 certified enviro ... more

DNA blood test detects lung cancer mutations

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers has reported at the European Lung Cancer Conference (ELCC) in Gen ... more

Sartorius Stedim Biotech acquires UK-based CRO, BioOutsource

Sartorius Stedim Biotech (SSB) acquired the Scottish company BioOutsource Ltd. The privately owned company based in Glasgow, UK, has been operating in the biotechnology market since 2007, and in the last twelve months earned revenue of around 9 million euros with approx. 85 employees. The c ... more

Belgian Start-up UgenTec Receives Funding from European Investors

UgenTec, a start-up company based in Belgium that develops laboratory software for automating PCR based DNA analysis, announced that it has received more than €1m in venture capital funding from a group of Belgian investors and an additional €250,000 in research funds from the IWT, a govern ... more

Mummified bodies reveal how tuberculosis ravaged the heart of 18th century Europe

Bodies found in a 200 year-old Hungarian crypt have revealed the secrets of how tuberculosis (TB) took hold in 18th century Europe, according to a research team led by the University of Warwick. A new study published in Nature Communications details how samples taken from naturally mummifie ... more

Trapping and watching motile cells

Optical imaging of highly motile cells or cells in suspension, such as bacterial systems, yeast cells, and immune cells, is a challenging task, in many cases it is just not possible. The human immunodeficiency virus (HIV), for example, can spread very efficiently from an infected T cell to ... more

All news on bioanalytics

Clinical Trial Moves Stem Cell Therapy for ALS Patients One Step Closer to Reality

Stem cells are a safe therapy for patients with amyotrophic lateral sclerosis (ALS), according to the results of a recently completed phase 1 clinical trial. Details of the trial, conducted by scientists in South Korea, are published in STEM CELLS Translational Medicine. The trial was the n ... more

Neural stem cell implants hold promise for treating epilepsy, other neurological disorders

A team of University of Florida Health researchers has successfully transplanted human stem cells that developed into fully functional neurons in a mouse model, a promising step toward finding new treatments for epilepsy and other neurological disorders. The findings are particularly encour ... more

Scientists find new link between diabetes and Alzheimer's

Researchers have uncovered a unique connection between diabetes and Alzheimer's disease, providing further evidence that a disease that robs people of their memories may be affected by elevated blood sugar, according to scientists at Washington University School of Medicine in St. Louis.Whi ... more

SYGNIS signs non-exclusive distribution agreement with Cambridge Bioscience Ltd. for UK and Ireland

SYGNIS AG announced a distribution agreement with Cambridge Bioscience for the commercialization of SYGNIS’ proprietary product portfolio in the UK and Ireland.Under the terms of the agreement, Cambridge Bioscience will promote, market, sell and support TruePrime™ products for primer-free W ... more

AmpliPhi Biosciences Announces New CEO

AmpliPhi BioSciences Corporation announced that Scott Salka has been appointed as the new CEO. Mr. Salka will replace Interim CEO and Chairman of AmpliPhi, Jeremy Curnock Cook, effective May 18. Mr. Curnock Cook will remain in his role as Chairman.Since 2010, Mr. Salka has served as CEO of ... more

cytena received EUR 1.1 million of seed capital from HTGF and a private investor

cytena GmbH has developed a device called cy-Clone to separate single cells. A consortium made up of a private investor and High-Tech Gründerfonds (HTGF), will provide EUR 1.1 million of seed capital. cytena GmbH will use this capital injection primarily to launch its product and to expand ... more

New material for creating artificial blood vessels

Blocked blood vessels can quickly become dangerous. It is often necessary to replace a blood vessel – either by another vessel taken from the body or even by artificial vascular prostheses. Together, Vienna University of Technology and Vienna Medical University have developed artificial blo ... more

IDT Opens Molecular Biology R&D Facility in Redwood City

Research and development for Integrated DNA Technologies' (IDT) validated molecular biology products will now be performed in a newly built facility in Redwood City, California. The 8,000 square foot building houses state-of-the-art labs that will allow IDT scientists to maximize the compan ... more

Facio partners with Evotec and initiates FSHD drug discovery programme

Evotec AG and Facio Therapies announced that they have entered into an agreement aimed at the identification of compounds showing activity as a potential treatment to stop the progression of FSHD (Facioscapulohumeral dystrophy), a muscle wasting disease. This agreement marks the start of fi ... more

apceth Names Ulrike Verzetnitsch as Chief Technical Office

apceth GmbH & Co. KG is continuing to expand its senior management team and has announced the appointment of Ulrike Verzetnitsch as Chief Technical Officer with immediate effect.In this newly created role, Ulrike Verzetnitsch will add considerable value to the company by leading apceth’s pr ... more

All news on biotechnology

Detecting lung cancer at an early stage

A new diagnostic method, namely spectral histopathology, facilitates marker-free detection of individual subtypes of lung cancers. It was developed by researchers at the PURE consortium at Ruhr-Universität Bochum (RUB). They have successfully applied it in collaboration with clinicians at t ... more

DNA blood test detects lung cancer mutations

Cancer DNA circulating in the bloodstream of lung cancer patients can provide doctors with vital mutation information that can help optimise treatment when tumour tissue is not available, an international group of researchers has reported at the European Lung Cancer Conference (ELCC) in Gen ... more

Aseptika Granted United States Patent for Biomarkers for Respiratory Infection Onset

Aseptika Limited announced that it has been granted a patent in the United States (US) protecting its invention for a test for respiratory infections, designed to be used by patients at home and by clinicians at the bedside of patients in hospitals. This will open up opportunities for the C ... more

Roche strengthens oncology translational research pipeline by acquiring CAPP Medical

Roche announced it has acquired CAPP Medical, a genomics research company founded by Stanford University oncologists and industry veterans, to advance the development of technology for cancer screening and monitoring through the detection of circulating tumor DNA (ctDNA) in blood.  CAPP Med ... more

Bio-marker set forms the basis for new blood test to detect colorectal cancer

Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European ... more

Philips enters into collaboration with Janssen to develop new handheld blood test

Royal Philips announced that it has entered into a multi-year development agreement with Janssen Pharmaceutica N.V.. The collaboration aims to develop a new handheld blood test to provide doctors with a novel tool to improve the care of patients with neuropsychiatric disorders.The collabora ... more

analytica Vietnam 2015 more international than ever

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends ... more

MDxHealth's ConfirmMDx Genes Detect Clinically Significant Prostate Cancer

MDxHealth SA announced that data demonstrating the prognostic value of its ConfirmMDx® for Prostate Cancer genes and technology was presented at the ASCO Genitourinary Cancers Symposium 2015.  The data support the ability to predict the presence of clinically significant cancer in biopsy-ne ... more

SkylineDx Appoints Oncologist as Acting as Chief Medical Officer

SkylineDx announced the appointment of Saad Usmani, MD, FACP, as their acting Chief Medical Officer.  Dr. Usmani is currently the Director of Clinical Research (Hematologic Malignancies) and Director of Plasma Cell Disorders at Carolinas HealthCare System’s Levine Cancer Institute in Charlo ... more

New screening tool could speed development of ovarian cancer drugs

University of Chicago Medicine researchers have built a model system that uses multiple cell types from patients to rapidly test compounds that could block the early steps in ovarian cancer metastasis. Their three-dimensional cell-culture system, adapted for high-throughput screening, has e ... more

All news on diagnostics

SYGNIS signs non-exclusive distribution agreement with Cambridge Bioscience Ltd. for UK and Ireland

SYGNIS AG announced a distribution agreement with Cambridge Bioscience for the commercialization of SYGNIS’ proprietary product portfolio in the UK and Ireland.Under the terms of the agreement, Cambridge Bioscience will promote, market, sell and support TruePrime™ products for primer-free W ... more

Sartorius Starts Off Fiscal 2015 with a Strong First Quarter

Sartorius started off fiscal 2015 with substantial double-digit gains in order intake, sales revenue and earnings. Group order intake rose 13.1%, excluding currency effects; this reported figure surged 22.7%. Sales climbed 17.2% in constant currencies; the reported figure, 27.0%. Operating ... more

Genevac Consolidate Evaporator & Freeze Dryer Operations In Germany

Genevac has announced, as of 1st April 2015, that LMS Consult GmbH (LMS) has been appointed as the exclusive German distributor for its market leading evaporator systems plus the freeze dryer range of its parent company - SP Scientific.For over 30 years - LMS Consulthave successfully sold a ... more

Ximbio Expands Team

Ximbio announced the expansion of its team, with two new appointments. Dr Hugh Spotswood has joined as Senior Business Manager, and Emily Haggerty as a Scientific Portfolio Associate. Hugh’s role as part of Ximbio is to head up the business development function to maximise the revenue creat ... more

INTEGRA Biosciences Opens German Subsidiary

Following on from the successful launch of subsidiaries in France, the UK and the USA - INTEGRA Biosciences has announced the opening in January 2015 of a new organisation based in Konstanz, Germany.Leveraging an existing knowledgeable local sales and service team – INTEGRA Biosciences Deut ... more

TÜV SÜD explains process maturity according to the new ISO 9001

The final version of the revised standard for quality management systems is scheduled for release by the International Organisation for Standardisation (ISO) in autumn 2015. Many organisations have already started to address the expected changes, which are aimed at strengthening the benefit ... more

analytica Vietnam 2015 more international than ever

This year's analytica Vietnam will have approximately 100 exhibitors from 15 countries, making it more international than ever. As part of the extensive program of related events, feature several international experts will pass on scientific background information about research and trends ... more

Sartorius Reviews Fiscal 2014 Results

Sartorius closed fiscal 2014 with significant gains in sales revenue and earnings. At the annual press conference in Goettingen, Germany, CEO Dr. Joachim Kreuzburg stated that the Group had even slightly exceeded its financial targets and reached important milestones: "Our largest division, ... more

Sartorius: Successful Business Year 2014

Sartorius successfully closed fiscal 2014 according to its preliminary figures, and even slightly exceeded its sales revenue and earnings targets. In addition, the Group is set to further sharpen its strategic profile based on the sale of its smallest division, Industrial Technologies, whic ... more

Seward appoints Dan Crothers as Managing Director

Seward Ltd. announced the appointment of Dan Crothers as Managing Director to direct strategy and implement a series of new developments within the Company. Dan, who has worked with Seward since 2008, assumes the new role after success in previous positions, including managing Seward’s Sing ... more

All news on lab technology

Synthon Announces Successful Outcomes from Phase III Study of Synthon’s Glatiramer Acetate

Synthon announces that data from the open-label extension of the Phase III GATE study of the Company’s generic glatiramer acetate in patients with relapsing remitting multiple sclerosis (RRMS) demonstrate that efficacy, safety and tolerability were maintained over the entire two-year study ... more

Ascendis Pharma A/S Announces Results of Phase 1 Study of TransCon Treprostinil

Ascendis Pharma A/S  announced that its Phase 1 single ascending dose study of TransCon Treprostinil produced dose-dependent increases in plasma treprostinil levels in-line with expectations.  However, treprostinil-related injection-site tolerability issues did not meet the criteria defined ... more

FDA Grants Fast Track Designation to Genzyme’s Investigational Substrate Reduction Therapy for the Treatment of Fabry Disease

Genzyme, a Sanofi company, announced that the Food and Drug Administration (FDA) has granted Fast Track designation for the development of GZ/SAR402671, a new investigational oral substrate reduction therapy for the treatment of Fabry disease.FDA’s Fast Track Drug Development Program is des ... more

Vetter Serializes the First Product for South Korea

Vetter has announced the manufacture of the first commercial batches with single-use identification numbers. Following the introduction of a comprehensive serialization service last year, the company has now implemented product serialization for secondary packaging. In accordance with the r ... more

Area-wide transition to open access is possible

The Max Planck Digital Library has put forward a study on the transformation of the subscription-driven system for scientific publications to an Open Access model. For the first time, quantitative parameters are presented showing that the liberation of scholarly literature is possible at no ... more

Genmab Announces Phase III Study of Arzerra® Met Primary Endpoint of Improved Progression-Free Survival in Patients with Relapsed CLL

Genmab A/S announced that the top-line results from the Phase III COMPLEMENT 2 study showed that treatment with Arzerra® (ofatumumab) plus fludarabine and cyclophosphamide met the primary endpoint of improved progression-free survival (PFS) in patients with relapsed CLL (p = 0.0036) compare ... more

More research on the protection of test animals needed

Every year, approximately 12 million animals are used in scientific experiments within the European Union, almost 3 million of them only in Germany. The amendment of the animal protection law provides that animals are better protected when used for scientific purposes. One of the special ob ... more

Recipharm appoints new General Manager for Recipharm Italia S.p.A

Recipharm has announced that Giorgio Bruno has been appointed General Manager of Recipharm Italia S.p.A. In this role, he will serve as CEO for all of Recipharm’s Italian operating companies which employ some 257 people at three sites and have revenues of €57m.Dr Bruno has long established ... more

New treatment for advanced melanoma

The European Medicines Agency (EMA) has recommended granting a marketing authorisation for Opdivo (nivolumab). Opdivo is recommended to be used on its own (monotherapy) for the treatment of adult patients with advanced (unresectable or metastatic) melanoma.For decades, chemotherapy was the ... more

Okayama University research: Enzyme-inhibitors treat drug-resistant epilepsy

Studies reveal how high-fat low-carb diets affect brain activity and highlight an approach for treating epilepsy with metabolic drugs. One percent of the world’s population suffer from epilepsy, and a third of sufferers cannot be treated with antiepileptic drugs. Diet control has been used ... more

All news on pharma

Clinical Trial Moves Stem Cell Therapy for ALS Patients One Step Closer to Reality

Stem cells are a safe therapy for patients with amyotrophic lateral sclerosis (ALS), according to the results of a recently completed phase 1 clinical trial. Details of the trial, conducted by scientists in South Korea, are published in STEM CELLS Translational Medicine. The trial was the n ... more

Neural stem cell implants hold promise for treating epilepsy, other neurological disorders

A team of University of Florida Health researchers has successfully transplanted human stem cells that developed into fully functional neurons in a mouse model, a promising step toward finding new treatments for epilepsy and other neurological disorders. The findings are particularly encour ... more

Scientists find new link between diabetes and Alzheimer's

Researchers have uncovered a unique connection between diabetes and Alzheimer's disease, providing further evidence that a disease that robs people of their memories may be affected by elevated blood sugar, according to scientists at Washington University School of Medicine in St. Louis.Whi ... more

NIH launches research to gaze deeply into your eyes

Five bold projects will develop new technology to noninvasively image cells of the eye in unprecedented detail. The National Eye Institute (NEI) announced the awards as part of its Audacious Goals Initiative. NEI has committed $3.8 million to the projects in 2015 and up to $17.9 million ove ... more

New material for creating artificial blood vessels

Blocked blood vessels can quickly become dangerous. It is often necessary to replace a blood vessel – either by another vessel taken from the body or even by artificial vascular prostheses. Together, Vienna University of Technology and Vienna Medical University have developed artificial blo ... more

Area-wide transition to open access is possible

The Max Planck Digital Library has put forward a study on the transformation of the subscription-driven system for scientific publications to an Open Access model. For the first time, quantitative parameters are presented showing that the liberation of scholarly literature is possible at no ... more

Scientists Gain Unique Insight into the Function of a Key Muscle Protein

Thanks to the first high-resolution structural analysis of the muscle protein α-actinin, scientists now have a better understanding of how muscles work. The analysis provides crucial information about the structure and function of this complex muscle protein and could lead to the developmen ... more

Is a small artificially composed virus fragment the key to a Chikungunya vaccine?

The mosquito transmitted Chikungunya virus, which causes Chikungunya fever, is spreading continuously. No vaccine is so far available. Researchers of the Paul-Ehrlich-Institut have experimentally recombined segments of the virus surface protein E2, thus creating artificial proteins. The dom ... more

X-ray laser reveals structure of blood pressure regulator

With a sophisticated X-ray analysis, a US-German team of scientists has solved the molecular structure of an important regulator for blood pressure in the human body. The study gives new insights into the function of this regulator and could aid the development of new medication with less s ... more

5 million euros for medical innovation Dutch government invests in the pearls of previous research

The Dutch Ministry of Economic Affairs has granted 2.5 million euros to extend seven promising research projects aimed at medical innovation. The projects, which are focused at debilitating and life-threatening diseases such as breast cancer, prostate cancer and thrombosis, are part of the ... more

All news on healthcare
News by department
News according to country
Companies in the news
News archive
Newsletters

bionity.com Newsletter

The bionity.com newsletter keeps you informed about the current events in the fields of biotechnology, life sciences and medicine with news, products, company profiles and technical information.
Current edition

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE